The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

One year results of a new in situ length-adjustable stent platform with a biodegradable Biolimus A9 eluting polymer: results of the CUSTOM-II trial

EuroInterv.2008;4:200-207.

1. University Medical Center Utrecht, Utrecht, The Netherlands; 2. Helios Klinikum Siegburg, Germany; 3. Cardiovascular Centre Aalst, Aalst, Belgium; 4. Barmherzigen Bruder Krankenhaus, Trier, Germany; 5. Institut Hospitalier Jacques Cartier, Massy, Franc

Aims: To assess the safety and efficacy of the XTENT® customisable drug-eluting stent system in the treatment of patients with single long or multiple coronary

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Improved renal function and blood pressure control following renal artery angioplasty: The Renal Artery Angioplasty in Patients with Renal Insufficiency and Hypertension Using a Dedicated Renal Stent Device Study (PRECISION)